VHB937, another TREM2 antibody, boosts chemotaxis and phagocytosis in vitro, while results from AD, Parkinson’s disease (PD), and multiple sclerosis mouse models show it can protect neuronal viability, reduce neuroinflammation, and mitigate astrogliosis [79, 80]. This evidence concerns the gene TREM2 and Alzheimer disease.